Prihlásiť sa Zaregistrujte sa zadarmo

Návratnosť imania spoločnosti Hancock Jaffe Laboratories Inc

Aká je hodnota metriky Návratnosť imania spoločnosti Hancock Jaffe Laboratories Inc?

Hodnota metriky Návratnosť imania spoločnosti Hancock Jaffe Laboratories Inc je -55.76%

Aká je definícia metriky Návratnosť imania?



Návratnosť imania (Return on equity - ROE) je rentabilita vlastného imania. Vypočíta sa vydelením čistého príjmu za fiškálny rok vlastným imaním.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Návratnosť imania spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Hancock Jaffe Laboratories Inc

Čomu sa venuje spoločnosť Hancock Jaffe Laboratories Inc?

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

Firmy s metrikou návratnosť imania podobnou spoločnosti Hancock Jaffe Laboratories Inc